Angiotensin converting enzyme inhibitor or angiotensin receptor blocker use among hypertensive US adults with albuminuria

Since 2003, US hypertension guidelines have recommended angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) as first-line antihypertensive therapy in the presence of albuminuria (urine albumin/creatinine ratio ≥300 mg/g). To examine national trends in guideline-con...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hypertension
Main Authors: Chu, Chi D., Powe, Neil R., McCulloch, Charles E., Banerjee, Tanushree, Crews, Deidra C., Saran, Rajiv, Bragg-Gresham, Jennifer, Morgenstern, Hal, Pavkov, Meda E., Saydah, Sharon H., Tuot, Delphine S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7725867/
https://ncbi.nlm.nih.gov/pubmed/33190561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.120.16281
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados